None listed
Conditions
Interventions
Intervention1: Milk protein with Cyanocobalamin: Group1 vitamin B12 (10ug/day) with Milk protein (500ml/day)will be supplemented from the end of 1st trimester (approx. 13 weeks)until delivery.
Contro
Sponsors
Government of India Ministry of Science Technology Department of Biotechnology
Eligibility
Inclusion criteria
Inclusion criteria: Pregnant women Exclusion criteria include: 1) Women with multiple pregnancies 2) Pregnant women with pre-existing medical conditions such as diabetes, hypertension, metabolic disorders, epilepsy etc 3) Pregnant women on medications 4) Pregnant women anticipating to move out of the study site before completion of the study 5) Assisted pregnancy
Exclusion criteria
Exclusion criteria: Excluded will be those mothers who anticipate moving out of the area before study completion, those with twin or multiple pregnancies, those who tested positive for hepatitis B (HBsAg), HIV or syphilis (VDRL) infections or those who are taking daily vitamin supplements in addition to folate and iron. Women with a serious pre-existing medical condition will be excluded, and these will be defined as conditions that require chronic or daily medical therapy. Examples include connective tissue diseases, hypertension not related to pregnancy, inflammatory bowel disease, active tuberculosis, symptomatic heart disease, and insulin-dependent diabetes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gestational weight gainTimepoint: during pregnancy | — |
Secondary
| Measure | Time frame |
|---|---|
| Methyl transfer kinetic at 3rd trimester and birth weight at Bangalore site. Birth weight at Pune site. Timepoint: during delivery | — |
Countries
India
Contacts
Public ContactDr Anura V Kurpad
St Johns National Academy of Health Sciences
Outcome results
None listed